美国 · SEC FORM 4
KalVista Pharmaceuticals, Inc.
KALV · — · CIK 0001348911 · Healthcare
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
31 同一窗口内观察到的 Form 4 交易行
13 sales · 18 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2025-04-09 · Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. · $235.5K
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出中等
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Yea ChristopherCHIEF DEVELOPMENT OFFICER
○▼○○▼▼○▼○
Palleiko Benjamin LCHIEF EXECUTIVE OFFICER
○▼○▼○▼○
Audhya Paul K.CHIEF MEDICAL OFFICER
○▼○○▼▼○
Sweeny NicoleChief Commercial Officer
○○▼▼○
Piekos BrianChief Financial Officer
○▼○
● 买入▼ 卖出○ 其他
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-04-09 · Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P..
近期 Form 4 活动
0买入
42卖出
49其他 Form 4 交易行
44SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出13 sale line(s) · 仅供背景
其他18 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
FINRA 报告中没有该股票代码的空头余额。
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-04-09 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | 买入 (P) | Common Stock | 25,000 | USD 9.42 | USD 235,500 | SEC 申报 ↗ |
| 2025-02-13 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | 买入 (P) | Common Stock | 61,700 | USD 9.33 | USD 575,661 | SEC 申报 ↗ |
| 2025-02-12 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | 买入 (P) | Common Stock | 100,000 | USD 9.23 | USD 923,000 | SEC 申报 ↗ |
| 2025-02-11 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | 买入 (P) | Common Stock | 26,703 | USD 9.18 | USD 245,134 | SEC 申报 ↗ |
| 2025-02-10 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | 买入 (P) | Common Stock | 4,137 | USD 9.14 | USD 37,812 | SEC 申报 ↗ |
| 2025-02-07 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | 买入 (P) | Common Stock | 73,649 | USD 9.29 | USD 684,199 | SEC 申报 ↗ |
| 2025-02-03 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | 买入 (P) | Common Stock | 14,562 | USD 9.22 | USD 134,262 | SEC 申报 ↗ |
| 2025-01-31 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | 买入 (P) | Common Stock | 11,754 | USD 8.89 | USD 104,493 | SEC 申报 ↗ |
| 2025-01-30 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | 买入 (P) | Common Stock | 43,707 | USD 8.76 | USD 382,873 | SEC 申报 ↗ |
| 2024-02-08 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | 买入 (P) | Common Stock | 29,747 | USD 14.70 | USD 437,281 | SEC 申报 ↗ |
| 2024-02-07 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | 买入 (P) | Common Stock | 51,827 | USD 14.56 | USD 754,601 | SEC 申报 ↗ |
| 2024-02-06 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | 买入 (P) | Common Stock | 4,474 | USD 14.74 | USD 65,947 | SEC 申报 ↗ |
| 2024-01-30 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | 买入 (P) | Common Stock | 88,099 | USD 14.47 | USD 1,274,793 | SEC 申报 ↗ |
| 2024-01-29 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | 买入 (P) | Common Stock | 80,600 | USD 14.22 | USD 1,146,132 | SEC 申报 ↗ |
| 2024-01-26 | Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings III, LLC; VHCP Management EG, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners EG, L.P.; Venrock Healthcare Capital Partners III, L.P. | 买入 (P) | Common Stock | 4,174 | USD 12.98 | USD 54,179 | SEC 申报 ↗ |
Form 4 申报证据
91 transaction lines in the latest 365-day window; 392 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-11 | Yea Christopher | D (D) | Common Stock | 229,918 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-11 | Sweeny Nicole | D (D) | Common Stock | 59,291 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-11 | Piekos Brian | D (D) | Common Stock | 21,661 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-11 | Yea Christopher | D (D) | Common Stock | 229,918 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-11 | Sweeny Nicole | D (D) | Common Stock | 59,291 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-11 | Piekos Brian | D (D) | Common Stock | 21,661 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-11 | Palleiko Benjamin L | D (D) | Common Stock | 479,989 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-11 | Audhya Paul K. | D (D) | Common Stock | 150,260 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-27 | Yea Christopher | 卖出 (S) | Common Stock | 33,800 | USD 26.78 | USD 905,164 | SEC 申报 ↗ |
| 2026-05-27 | Yea Christopher | 期权行权／转换 (M) | Common Stock | 33,800 | USD 7.07 | USD 238,966 | SEC 申报 ↗ |
| 2026-05-26 | Yea Christopher | 卖出 (S) | Common Stock | 1,966 | USD 26.78 | USD 52,649 | SEC 申报 ↗ |
| 2026-05-26 | Sweeny Nicole | 卖出 (S) | Common Stock | 1,489 | USD 26.78 | USD 39,875 | SEC 申报 ↗ |
| 2026-05-26 | Audhya Paul K. | 卖出 (S) | Common Stock | 2,239 | USD 26.78 | USD 59,960 | SEC 申报 ↗ |
| 2026-05-22 | Yea Christopher | 期权行权／转换 (M) | Common Stock | 3,125 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-22 | Sweeny Nicole | 期权行权／转换 (M) | Common Stock | 5,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-22 | Audhya Paul K. | 期权行权／转换 (M) | Common Stock | 5,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-22 | Yea Christopher | 卖出 (S) | Common Stock | 2,358 | USD 26.78 | USD 63,147 | SEC 申报 ↗ |
| 2026-05-22 | Sweeny Nicole | 卖出 (S) | Common Stock | 1,861 | USD 26.78 | USD 49,838 | SEC 申报 ↗ |
| 2026-05-22 | Piekos Brian | 卖出 (S) | Common Stock | 1,489 | USD 26.78 | USD 39,875 | SEC 申报 ↗ |
| 2026-05-22 | Palleiko Benjamin L | 卖出 (S) | Common Stock | 10,926 | USD 26.78 | USD 292,598 | SEC 申报 ↗ |
| 2026-05-22 | Audhya Paul K. | 卖出 (S) | Common Stock | 2,685 | USD 26.78 | USD 71,904 | SEC 申报 ↗ |
| 2026-05-21 | Yea Christopher | 期权行权／转换 (M) | Common Stock | 3,750 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-21 | Sweeny Nicole | 期权行权／转换 (M) | Common Stock | 6,250 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-21 | Piekos Brian | 期权行权／转换 (M) | Common Stock | 5,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-21 | Palleiko Benjamin L | 期权行权／转换 (M) | Common Stock | 23,250 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-21 | Audhya Paul K. | 期权行权／转换 (M) | Common Stock | 6,250 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-18 | Yea Christopher | 卖出 (S) | Common Stock | 1,108 | USD 26.76 | USD 29,650 | SEC 申报 ↗ |
| 2026-05-18 | Palleiko Benjamin L | 卖出 (S) | Common Stock | 1,129 | USD 26.76 | USD 30,212 | SEC 申报 ↗ |
| 2026-05-18 | Audhya Paul K. | 卖出 (S) | Common Stock | 1,032 | USD 26.76 | USD 27,616 | SEC 申报 ↗ |
| 2026-05-17 | Yea Christopher | 期权行权／转换 (M) | Common Stock | 1,774 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-17 | Palleiko Benjamin L | 期权行权／转换 (M) | Common Stock | 2,419 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-17 | Audhya Paul K. | 期权行权／转换 (M) | Common Stock | 2,419 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-12 | Palleiko Benjamin L | 卖出 (S) | Common Stock | 3,322 | USD 26.71 | USD 88,731 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | KALV |
| CIK | 0001348911 |
| 行业 | Healthcare |
| 细分行业 | — Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | — |
数据覆盖
| 本地 Form 4 历史 | 392 transaction lines from 2020-02-05 to 2026-06-11 34 P purchase lines · 204 S sale lines · 154 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.